Navigation Links
Encorium Reports Second Quarter 2010 Financial Results
Date:8/17/2010

WAYNE, Pa., Aug. 17 /PRNewswire-FirstCall/ -- Encorium Group, Inc. (Nasdaq: ENCO), a full service multinational clinical research organization (CRO) conducting studies in over 30 countries for many of the world's leading pharmaceutical and biotechnology companies, today announced its financial results for the second quarter and six months ended June 30, 2010.

As previously announced, on July 16, 2009 the Company sold substantially all of the assets relating to its U.S. line of business to Pierrel Research USA, Inc., the result of which the Company no longer has any employees or significant operations in the United States.  Due to this sale, for the three months ended June 30, 2010, the results of the U.S. business have been presented as discontinued operations in the Company's consolidated financial statements.

2010 Second Quarter Financial ResultsNet revenue for the second quarter of 2010 was 3.8 million, a $700 thousand decrease from $4.5 million for the second quarter of 2009.  The decrease in net revenues was primarily attributable to reduced new business awards, contract cancellations as well as performance of unexpected out of scope work for which revenue can not be recognized until corresponding change orders are executed with the clients.  Of the $700 thousand decrease, approximately $325 thousand was due to unfavorable foreign currency fluctuations for the three months ended June 30, 2010.  

The Company had a consolidated backlog at June 30, 2010 of $16.6 million compared to backlog at March 31, 2010 of $14.7 million and backlog of $19.6 million at June 30, 2009.  For the six months ended June 30, 2010 we obtained approximately $9.1 million of new business awards as compared to approximately $4.8 million for the six months ended June 30, 2009.

Direct expenses for the second quarter of 2010 declined to $2.6 million, or
'/>"/>

SOURCE Encorium Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Encorium Group Signs $6.2 Million of New Contracts Mainly for Vaccines Clinical Trials
2. Encorium Announces the Initiation of a Strategic Partnership With Prologue Research After the Postponement of Negotiations Regarding Its Planned Acquisition; Strategic Reorganization and Cost Reduction Plan Initiated as Strategic Alternatives are Investig
3. Encorium Group Provides Update to LOI with Respect to the Sale of its U.S. Business
4. Encorium Re-Appoints Dr. Kai Lindevall as Chief Executive Officer and Appoints Current Director, Shahab Fatheazam, Chairman of the Board
5. Encorium Group, Inc. Appoints Sari Laitinen to Board of Directors
6. Encorium Group, Inc. Acquires Progenitor International Research, a Vaccine Focused Emerging Market CRO
7. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
8. Spherix Reports Second Quarter Earnings
9. Tapestry Reports Second Quarter 2007 Results
10. Callisto Reports on Second-Quarter 2007 Milestones
11. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)...  Advanced Medical Isotope Corporation ("AMIC") (OTCQB: ADMD), a ... development of brachytherapy devices and medical isotopes for ... has filed a de novo submission ... marketing clearance for its patented Y-90 RadioGel(TM) device ... Drug and Cosmetic Act (the "Act").  ...
(Date:12/24/2014)... 23, 2014   Synageva BioPharma Corp. ... developing therapeutic products for rare disorders, today announced ... the Marketing Authorization Application (MAA) for sebelipase alfa ... company,s request for accelerated assessment, which has the ... The MAA, and the Biologics ...
(Date:12/24/2014)... Dec. 23, 2014  The American Diabetes Association ... target for people with diabetes and that all ... doses of statins, in keeping with recent changes ... the American College of Cardiology (ACC) and American ... the most recent changes to the Association,s annual ...
Breaking Medicine Technology:Advanced Medical Isotope Corporation Files a "de novo" Submission for Y-90 RadioGel(TM) Device 2Advanced Medical Isotope Corporation Files a "de novo" Submission for Y-90 RadioGel(TM) Device 3Synageva BioPharma Announces Sebelipase Alfa Marketing Authorization Application Validated By The EMA 2Synageva BioPharma Announces Sebelipase Alfa Marketing Authorization Application Validated By The EMA 3New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 2New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 3New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 4
... May 31, 2011 Reportlinker.com announces that ... in its catalogue: Global ... 2011-2018 http://www.reportlinker.com/p0512284/Global-Market-for-Hormonal-Contraceptives-and-Infertility-Drugs-2011-2018.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication ... over ten key marketed products and indentifies ...
... NEW YORK, May 30, 2011 Reportlinker.com ... is available in its catalogue: ... http://www.reportlinker.com/p0535949/The-Antibacterials-Market-Outlook-to-2016.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication ... report provides comprehensive coverage of the global ...
Cached Medicine Technology:Reportlinker Adds Global Market for Hormonal Contraceptives and Infertility Drugs, 2011-2018 2Reportlinker Adds Global Market for Hormonal Contraceptives and Infertility Drugs, 2011-2018 3Reportlinker Adds Global Market for Hormonal Contraceptives and Infertility Drugs, 2011-2018 4Reportlinker Adds Global Market for Hormonal Contraceptives and Infertility Drugs, 2011-2018 5Reportlinker Adds Global Market for Hormonal Contraceptives and Infertility Drugs, 2011-2018 6Reportlinker Adds Global Market for Hormonal Contraceptives and Infertility Drugs, 2011-2018 7Reportlinker Adds The Antibacterials Market Outlook to 2016 2Reportlinker Adds The Antibacterials Market Outlook to 2016 3Reportlinker Adds The Antibacterials Market Outlook to 2016 4
(Date:12/26/2014)... Parker & Sons, Inc. a ... heating, cooling and plumbing contractor services throughout Arizona ... in 2014 with regard to air-conditioning systems. Residential ... known for its incredibly hot summers. Working with ... and details of a wide variety of systems ...
(Date:12/25/2014)... 2014 The report “Nintedanib (Colorectal ... focuses on the current treatment landscape, unmet needs, ... cancer market. Stivarga is a drug which is ... cancer. Boehringer Ingelheim is developing nintedanib (BIBF-1120), an ... refractory CRC in the US, Europe, and Japan. ...
(Date:12/25/2014)... December 26, 2014 Recently, iFitDress.com, the popular ... women, has announced its new selection of black one-shoulder ... on sale now; they are available at discounted prices, up ... “The promotion will last for three weeks only. You know, ... Those who are interested in our new items can visit ...
(Date:12/25/2014)... (PRWEB) December 25, 2014 BambooFlooringChina.com sells ... high quality bamboo flooring. Today, the company announces ... in many styles and colors. , BambooFlooringChina.com is the ... CEO, the promotion is valid until Jan. 20, 2015. ... strips and woven with a natural thread. All the ...
(Date:12/25/2014)... Dennis Thompson HealthDay Reporter ... children with complex chronic illnesses can receive effective, less expensive ... with easy access to a team of dedicated health care ... to become seriously ill and need either hospitalization or a ... an enhanced medical home clinic at the University of Texas ...
Breaking Medicine News(10 mins):Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 2Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 4Health News:iFitDress.com: Black One-Shoulder Cocktail Dresses for 2015 2Health News:Various Styles of Bamboo Mats in Many Colors from BambooFlooringChina.com 2Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 2Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 3
... transparency for quality improvement.CHICAGO, April 6 ... www.siemens.com/healthcare ) will ... with Soarian(R) Quality Measures, enabled by the REMIND(TM) Platform, ... Society (HIMSS) 2009 Annual Conference and Exhibition in Chicago ...
... -- Harris Corporation (NYSE: HRS ) ... www.ctisus.com ) to deliver intuitive navigation to ... allied healthcare professionals who access the site every day ... and is maintained by The Advanced Medical Imaging Laboratory, ...
... (HIMSS,09, Booth #3974) -- Harris Corporation (NYSE: ... $14 million contract by Evolvent Technologies, Inc., to develop ... System,s global Healthcare Artifact and Image Management Solution (HAIMS). ... potential for four one-year incentive options. The announcement ...
... invites customers to just ,have fun, and use social ... 6 Baxa Corporation, a leading developer of technology ... medications, has joined the social media craze by hosting ... Group. More and more healthcare facilities, medical device ...
... ATLANTA, April 6 CryoLife, Inc., (NYSE: ... and tissue processing company, today announced it has ... of Defense (DoD) Appropriations Bill to continue further ... studies of CryoLife,s BioFoam(R) Surgical Matrix, a protein ...
... small study hint at cancer-preventing ability, researcher says , , MONDAY, ... of broccoli sprouts appeared to reduce the risk of stomach ... Gastric cancer thus joins a long list of malignancies for ... diet that contains broccoli -- including cancer of the esophagus, ...
Cached Medicine News:Health News:Siemens Enhances Knowledge-Driven Solutions to Support Provider Quality of Care Initiatives 2Health News:Siemens Enhances Knowledge-Driven Solutions to Support Provider Quality of Care Initiatives 3Health News:Harris Corporation Redesigning Popular Radiology Web Site to Enhance Content Management and Accessibility 2Health News:Harris Corporation Awarded $14 Million Contract to Develop Multi-Hospital Military Health System Network with Image-Sharing Capabilities 2Health News:Baxa Corporation Gets Social With Facebook and LinkedIn 2Health News:Baxa Corporation Gets Social With Facebook and LinkedIn 3Health News:Department of Defense Awards CryoLife $1.7 million to Develop BioFoam Hemostatic Technology 2Health News:Department of Defense Awards CryoLife $1.7 million to Develop BioFoam Hemostatic Technology 3Health News:Broccoli May Ward Off Serious Stomach Ailments 2Health News:Broccoli May Ward Off Serious Stomach Ailments 3
The ENDO MINI-RETRACT™ 5 mm instrument has application in a variety of gynecologic, abdominal, urologic, thoracic and endoscopic procedures for temporary retraction of tissue and small tubular ...
The ENDO PEANUT™ instrument has indications in endoscopic surgery for swabbing small amounts of ?uid or for blunt dissection of soft tissue(s) and structures, or as an aid in controlling minor ...
... Introducing the widest offering of single-use instruments on ... long 43cm lengths for Bariatric Surgery. , ... Extended insulation covers the pivot points to reduce ... A 4mm universal cord, which eliminates gapping at ...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
Medicine Products: